The EHA2023 Hybrid Congress featured state-of-the-art presentations on a broad range of topics that are relevant to the treatment of patients with ......READ MORE
Data that were presented at the EHA2023 Hybrid Congress stimulated discussions about the emerging goals of treatment-free remission (TFR) in chroni......READ MORE
At the EHA2023 Hybrid Congress, there were a number of presentations on the late-line treatment of chronic-phase chronic myeloid leukemia (CML). Se......READ MORE
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, ......READ MORE
Currently, only a subset of patients with chronic myeloid leukemia (CML) pursuing treatment-free remission (TFR) enjoy success. At the 64th ASH Ann......READ MORE
At the 64th ASH Annual Meeting and Exposition, researchers continued to explore new ways to optimize the treatment of chronic phase chronic myeloid......READ MORE
